Targeted therapy of hepatocellular carcinoma by histone deacetylase inhibitor and preliminary study on the targeted imaging probe [18F]FAHA.

碩士 === 國立陽明大學 === 生物醫學影像暨放射科學系 === 101 === Histone deacetylase (HDAC) inhibitors are emerging as a new class of anticancer agents. Recent studies have shown HDACIs have notable effects on cell proliferation, apoptosis, differentiation and angiogenesis in vitro and in vivo. Currently, there are pha...

Full description

Bibliographic Details
Main Authors: Yi-Shiuan Chen, 陳懿璿
Other Authors: Ran-Chou Chen
Format: Others
Language:zh-TW
Published: 2013
Online Access:http://ndltd.ncl.edu.tw/handle/60667104232816495752